Home » Topics » Regulatory » Patents

Patents
RSS

New treatment strategies for transplant rejection described in recent patent lterature

Nov. 14, 2008

IRM reports novel antiobesity compounds in a recent patent

Nov. 14, 2008

Recent Ranbaxy patents disclose novel agents for inflammatory disorders

Nov. 14, 2008

New diagnostic agents imparted by Merck Eprova

Nov. 13, 2008

Recent Novartis patent discloses novel antiinflammatory agents

Nov. 13, 2008

Novel antiobesity agents disclosed in recent patents

Nov. 13, 2008

Novel NNRTIs reported by Roche

Nov. 12, 2008

Recent Bayer Schering patent reports novel antiviral agents

Nov. 12, 2008

Novel agents for treating endocrine-related disorders disclosed in recent patent literature

Nov. 12, 2008

Novel agents for psychiatric disorders described in recent patent literature

Nov. 11, 2008

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...